Qualys (QLYS) Rallies As Earnings Beat And FedRAMP Win Draw Traders

Qualys Inc. stocks have been trading up by 8.84 percent following bullish sentiment around its cybersecurity platform growth potential.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading QLYS

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways For QLYS Traders

Q1 delivered a clean beat, with non-GAAP EPS of $1.95 vs. $1.80 and revenue of $175.6M vs. $173.6M, powered by AI-driven pre-breach risk management demand.
Management nudged FY26 EPS to $7.44–$7.65 and revenue to $721M–$727M, putting QLYS slightly ahead of Street models.
Q2 guidance of EPS $1.73–$1.80 and revenue $177.5M–$179.5M points to steady ~10% growth and firm margins.
Several banks cut QLYS price targets even while sticking with Neutral, Sector Perform, or Buy/Outperform ratings.
A new FedRAMP High Authorization for TotalCloud CNAPP opens more doors with U.S. federal and heavily regulated customers.

Live Update At 16:02:58 EDT: On Monday, May 18, 2026 Qualys Inc. stock [NASDAQ: QLYS] is trending up by 8.84%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

QLYS has been grinding higher on the chart. From 2026/04/23 to 2026/05/18, the stock climbed from roughly $84 to a $97.98 close, with several strong sessions above $90. That’s a solid uptrend, not a meme spike. For active trading, this kind of steady stair-step move often signals real institutional interest behind the tape.

Intraday on 2026/05/18, QLYS held a tight range around $96–$98 for hours, closing right under the highs. That intraday stability, after a multi-day run, tells you dip-buyers were supporting the name instead of bailing into strength.

Under the hood, QLYS just printed Q1 revenue of $175.6M with net income of $50.6M and EBITDA near $68M. Profit margins are hefty: gross margin about 82.9%, EBIT margin roughly 35.8%. This is a high-margin cybersecurity platform, not a cash-burning story stock.

More Breaking News

Valuation is no longer wild. With a P/E around 16.2 and price-to-sales near 4.6, QLYS trades more like a mature, profitable software name. Low leverage (debt-to-equity ~0.09) and strong returns on equity north of 30% show a clean balance sheet. For traders, that mix often limits blow-up risk, but it also means the next big move likely needs a growth catalyst, not just “value.”

Why Traders Are Watching QLYS Right Now

The latest quarter gave traders a clear data point: QLYS executes. Non-GAAP EPS of $1.95 beat the $1.80 mark, and revenue of $175.6M topped expectations around $173.6M. Management didn’t just beat; they backed it up by raising FY26 EPS guidance to $7.44–$7.65 and revenue to $721M–$727M. That’s a modest bump, but it confirms the cybersecurity story is still growing at a controlled clip.

Yet the Street’s reaction to QLYS is anything but euphoric. RBC nudged its target to $90, basically right where the stock is trading, and kept a Sector Perform call. Wedbush sliced its target to $125 from $155 but still says Outperform, while the average target across firms sits near $110.35 with a Hold consensus. Translation for traders: analysts see upside from roughly $90, but they’re not betting on a face-ripping breakout.

Others reset their numbers more aggressively. Piper Sandler cut QLYS to a $100 target from $135 and stayed Neutral, arguing the roughly 10% year-over-year growth and limited near-term AI payoff cap the story for now. Scotiabank and Canaccord also lowered targets to $100 and $125, respectively, even as they pointed to channel growth and new AI offerings.

Where QLYS gets interesting for momentum traders is on the product and regulatory side. The Enterprise TruRisk Management (ETM) platform and QFlex are seeing traction. On top of that, FedRAMP High Authorization for the TotalCloud CNAPP solution opens doors across U.S. agencies and heavily regulated industries. That kind of credential can quietly build a multi-year pipeline. The catch: those wins show up in billings and backlog first, not overnight revenue spikes, so the stock may trade in swings around each new data point.

Conclusion

For active traders, QLYS now sits in a classic “good company, debated stock” zone. The tape is bullish: a controlled uptrend from the mid-$80s to the high-$90s, tight intraday ranges, and strong support on dips. Fundamentals back that move, with thick margins, strong cash flow around $95M in operating cash for the quarter, and low leverage. Guidance for Q2 and FY26 shows steady growth, not a slowdown.

But the billings growth around 8% and cautious analyst tone keep a lid on runaway optimism. Several firms cut price targets on QLYS even as they reiterated Buy or Outperform calls, signaling that valuation, not execution, is the sticking point. For swing traders, that tension can create clean range setups: support guided by fundamentals, resistance defined by trimmed targets and growth doubts.

The new FedRAMP High Authorization for TotalCloud CNAPP gives QLYS a credible long-term angle in government and regulated verticals. Any future quarter that shows billings reacceleration linked to that channel could reset the narrative fast. Until then, QLYS is a name to trade with a plan: focus on key levels, respect the trend, and, as Tim Sykes always drills into students, “cut losses quickly and move on to the next play.” In the same spirit of disciplined trading, as Tim Bohen, lead trainer with StocksToTrade says, “For me, trading is more about managing risk than finding the next big mover.” This coverage is for educational and research purposes only and is meant to help traders think through the QLYS setup with a clear, disciplined mindset.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!